Peter R. Wielinga

The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

Glen Reid, Peter R. Wielinga, Noam Zelcer et al. · Proceedings of the National Academy of Sciences · 2003 · 539 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

Markos Leggas, Masashi Adachi, George L. Scheffer et al. · Molecular and Cellular Biology · 2004 · 414 citations · Full text

Medicine, Oncology, Pharmacology +17

Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5

Glen Reid, Peter R. Wielinga, Noam Zelcer et al. · Molecular Pharmacology · 2003 · 366 citations · Full text

Medicine, Oncology, Pharmacology +17

The Effect of Bcrp1 (Abcg2) on the <i>In vivo</i> Pharmacokinetics and Brain Penetration of Imatinib Mesylate (Gleevec): Implications for the Use of Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib in Patients

Pauline Breedveld, Dick Pluim, Greta Cipriani et al. · Cancer Research · 2005 · 351 citations

Medicine, Pharmacokinetics, Pharmacology +16

Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)

Noam Zelcer, Glen Reid, Peter R. Wielinga et al. · Biochemical Journal · 2003 · 311 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17